Read More Pharma Industry News Blueprint Medicines strikes $1.7bn worth deal with Roche for pralsetinib Swiss pharma giant Roche and US precision therapy company Blueprint Medicines have entered into a worldwide licensing and… bypharmanewsdailyJuly 15, 2020
